Epidermolysis Bullosa (EB) Slice
New York
Approved
Genes
Conditions
- Dystrophic Epidermolysis Bullosa (DEB)
- Epidermolysis Bullosa Dystrophica
- Epidermolysis Bullosa (EB)
- Acral Peeling Skin Syndrome
- Epidermolysis Bullosa Simplex
- Generalized Atrophic Benign Epidermolysis Bullosa (GABEB)
- Herlitz Junctional Epidermolysis Bullosa
- Mitis Junctional Epidermolysis Bullosa
- Non-Herlitz Junctional Epidermolysis Bullosa
Clinical Utility
- Identification of the specific molecular basis of a hereditary blistering disorder
- Genetic counseling and recurrence risk assessment
Lab Method
- Next-Gen Sequencing
Important Information
If an affected individual is found by Slice-EB to have only a single mutation in a gene with recessive inheritance, deletion/duplication analysis of that gene can be performed at no additional cost. Patient samples sent for Slice will not be evaluated for secondary findings and therefore will not receive secondary findings as part of their result.
Test Code
707
CPT Codes*
81406x2, 81479x1
ABN Required
No
Turnaround Time**
6 weeks (4 weeks for newborns < 1 month)
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing